Cargando…
Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations
Anemia is an underrecognized but characteristic feature of chronic kidney disease (CKD), associated with significant cardiovascular morbidity, hospitalization, and mortality. Since their inception nearly two decades ago, erythropoiesis-stimulating agents (ESAs) have revolutionized the care of patien...
Autores principales: | Schmidt, Rebecca J, Dalton, Cheryl L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147011/ https://www.ncbi.nlm.nih.gov/pubmed/17910755 http://dx.doi.org/10.1186/1750-4732-1-14 |
Ejemplares similares
-
Step-Wise Management of Anemia in Patients With Chronic Kidney
Disease in Primary Care: Qualitative Study
por: Delanerolle, Gayathri, et al.
Publicado: (2023) -
Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
por: Ganz, Tomas, et al.
Publicado: (2023) -
Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
por: Hayat, Amir, et al.
Publicado: (2008) -
Contemporary outcomes of anemia in US patients with chronic kidney disease
por: Wittbrodt, Eric T, et al.
Publicado: (2021) -
Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2023)